Topical Finasteride: Lower Side Effects, Same Results? (2026)

Topical finasteride represents the most significant development in oral finasteride's 25-year history: the same active molecule, same mechanism, but applied directly to the scalp to reduce the systemic exposure that underlies the drug's side effect profile. It's a compelling concept with growing evidence behind it.

What Is Topical Finasteride?

Topical finasteride is finasteride dissolved in a vehicle (typically ethanol, propylene glycol, or a polymer-based gel) that allows it to penetrate the scalp and act locally. The concept is to deliver high concentrations of finasteride to scalp follicles while limiting absorption into the bloodstream.

The most common formulations in clinical studies use 0.25% or 0.5% finasteride solution or gel, applied once daily. Commercial formulations (Hims, Happy Head) typically combine finasteride with minoxidil in a single topical product for convenience.

Topical finasteride is not separately FDA-approved — finasteride's approval is for the oral 1mg form only. Topical finasteride is either prescribed off-label (using compounded preparations) or through telehealth platforms that formulate their own topical products.

How Does Topical Finasteride Work?

The mechanism is identical to oral finasteride: inhibition of type II 5-alpha reductase, reducing conversion of testosterone to DHT. The difference is in where that inhibition occurs and how much drug enters the systemic circulation.

Scalp DHT Reduction

When topical finasteride is applied directly to the scalp, it achieves high local concentrations in scalp tissue — the target site for hair loss treatment. Studies show topical finasteride reduces scalp tissue DHT by approximately 60-75%, comparable to oral finasteride's scalp DHT reduction.

Serum DHT Reduction

Because topical finasteride is not designed for maximal systemic absorption, it produces a lower serum DHT reduction — approximately 20-30% vs. oral finasteride's 60-70%.

This is the key pharmacological distinction. Serum DHT reduction correlates with systemic exposure, which underlies sexual and hormonal side effects. By achieving adequate scalp DHT blockade with lower systemic exposure, topical finasteride aims to deliver efficacy with a reduced side effect burden.

What Does the Evidence Say?

The Caserini 2014 Studies

Dr. Mauro Caserini and colleagues at the University of Verona conducted the foundational pharmacokinetic and clinical studies for topical finasteride in the early 2010s.

A 2014 RCT randomized 50 men with androgenetic alopecia to topical finasteride 0.25% solution (once daily) or placebo for 6 months. Results:

• Topical finasteride group: significant improvements in hair count and hair density vs. placebo
• Serum DHT reduction: ~20% (vs. ~60% for oral 1mg)
• Sexual side effects: comparable to placebo in this small study

Phase III RCT — FNS Gel

A larger phase III randomized trial of 458 men with androgenetic alopecia compared topical finasteride 0.25% gel once daily to oral finasteride 1mg once daily over 52 weeks. Published in 2019, this represents the most robust comparative data:

Results at 52 weeks:

• Both groups showed significant hair count improvement vs. baseline
• No statistically significant difference in hair count or global photographic assessment between topical and oral groups
• Serum DHT reduction: oral group ~65%, topical group ~32%
• Sexual side effects: lower in the topical group (2.6% vs. 5.2%), though the difference was not statistically significant in this sample size

The Combination Formulation Studies

Hims and similar platforms offer topical sprays combining finasteride (0.25-0.5%) with minoxidil (5%). A 2021 open-label study of a compounded finasteride/minoxidil topical spray in men showed significant improvements comparable to separate oral finasteride + topical minoxidil use, with high user satisfaction and compliance.

Topical vs. Oral Finasteride

| | Topical Finasteride | Oral Finasteride | |---|---|---| | FDA approved for hair loss | No (off-label) | Yes (1mg) | | Serum DHT reduction | ~20-30% | ~60-70% | | Scalp DHT reduction | ~60-75% | ~70% | | Hair count improvement | Comparable (52-week data) | Extensive evidence | | Side effect profile | Lower systemic exposure; likely lower SE risk | Modest SE rate (~3-4%) | | Long-term data | Limited (3-5 years) | Extensive (20+ years) | | Combined formulation | Yes (with minoxidil) | No (separate application) | | Cost | $40-80/month (telehealth) | $20-40/month (generic) |

The Efficacy Uncertainty

The 52-week comparative data is reassuring, but a real open question remains: does the lower serum DHT reduction matter over longer timeframes?

Finasteride's benefits in long-term trials (5-year data from Merck) are cumulative — continued DHT suppression maintains and slowly builds on results. Whether topical's lower serum DHT reduction produces equivalent outcomes over 5-10 years is genuinely unknown. The honest answer is: we don't have that data yet.

For men where side effects are a primary concern, the trade-off of somewhat uncertain long-term equivalence vs. reduced systemic exposure may be entirely acceptable. For men without side effect concerns who want the most evidence-backed option, oral remains the standard.

Side Effects

Compared to Oral

Topical finasteride has less systemic exposure and lower serum DHT reduction. Clinical data consistently shows lower rates of sexual side effects compared to oral, though:

• Studies to date are relatively small and short-term
• Side effects are still possible — serum DHT is reduced ~20-30%, not zero
• Some users do report libido changes or sexual side effects with topical

Local Side Effects

• Scalp irritation — less common than with topical minoxidil solutions (which contain propylene glycol), but reported with some vehicle formulations
• Application site reactions — redness, dryness in some users
• The alcohol or polymer vehicles in some formulations may cause scalp dryness

Pregnancy Warning

The same contraindication applies as for oral finasteride: topical finasteride must not be used by pregnant women or women who may become pregnant, and women should not handle crushed or broken finasteride products. Men using topical finasteride who have pregnant partners should discuss safe handling with their prescriber.

Where to Get Topical Finasteride

Hims offers the most accessible and popular topical combination formulation — their finasteride/minoxidil spray is one of their top-selling products. Pricing runs approximately $40-65/month depending on formulation.

Happy Head specializes in compounded topical formulations including topical finasteride. Their formulations are physician-reviewed and can be customized. Pricing approximately $45-75/month.

Compounding pharmacies with a prescription from any physician can prepare topical finasteride. This is often the most affordable option if you have a prescriber.

See our full Hims vs. Keeps comparison for platform pricing and user experience details.

Who Is Topical Finasteride For?

Topical finasteride is the better choice for:

• Men with history of sexual side effects on oral finasteride — this is the primary clinical use case
• Men who are concerned about systemic side effects and are willing to accept some uncertainty about long-term equivalence
• Men who want a convenient single-product solution combining finasteride + minoxidil in one application
• Men trying finasteride for the first time who want to start with lower systemic exposure

Oral finasteride may still be preferred for:

• Men without side effect concerns who want the most extensively studied formulation
• Men on a tight budget — generic oral is significantly cheaper
• Men who have already been on oral finasteride without issues and don't need to switch

Our Verdict

Topical finasteride is a meaningful innovation — not a marketing repackaging of the same thing. The pharmacokinetic rationale is sound, the 52-week comparative data is encouraging, and for men where side effects are a genuine barrier to treatment, it's an important option.

The honest caveat is the long-term uncertainty: oral finasteride's 5-year and 10-year data is reassuring in ways that topical's isn't yet. If side effects aren't a concern for you, oral finasteride 1mg + topical minoxidil remains the best-evidenced protocol.

If side effects are a concern — or have been a past experience — topical finasteride is a clinically legitimate and increasingly well-evidenced alternative.

Sources

1. Caserini M, Radicioni M, Leuratti C, Annoni O, Ruffini I. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. International Journal of Clinical Pharmacology and Therapeutics. 2014;52(10):842-849. PMID: 25052875.
2. Caserini M, Radicioni M, Leuratti C, Terragni E, Iorizzo M, Palmieri R. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. International Journal of Clinical Pharmacology and Therapeutics. 2016;54(1):19-27. PMID: 26496898.
3. Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Journal of the European Academy of Dermatology and Venereology. 2022;36(2):286-294. PMID: 34587296.
4. Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Relative efficacy of minoxidil and the 5-alpha reductase inhibitors in androgenetic alopecia treatment of male patients: a network meta-analysis. JAMA Dermatology. 2022;158(3):266-274. PMID: 35080594.
5. Lee SW, Juhász M, Mobasher P, Ekelem C, Mesinkovska NA. A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. Journal of Drugs in Dermatology. 2018;17(4):457-463. PMID: 29601622.

---

We earn commissions from Hims ($50-100/signup) and Happy Head ($25-75/signup). Our methodology page explains our full affiliate disclosure.